Mesoblast Limited vs Wix.Com Ltd — how do they compare? Mesoblast Limited trades at $16.68 (market cap $2.21B), while Wix.Com Ltd trades at $66.5 (market cap $2.79B). The key difference: Wix.Com Ltd is the larger of the two by market cap, and Mesoblast Limited is trading nearer its 52-week high, Wix.Com Ltd nearer its low. Which is the better fit depends on your goals.
| MESO | WIX | |
|---|---|---|
Market Cap | $2.21B | $2.79B |
Sector | Technology | Technology |
52-Week High | $20.96 | $184.24 |
52-Week Low | $12.88 | $40.43 |
Enterprise Value | $2.21B | $3.87B |
Trailing returns across standard periods
Mesoblast Limited is a global leader in allogeneic cellular medicines. The company develops innovative, commercially-ready mesenchymal lineage cell (MLC) technology for the treatment of various inflammatory and cardiovascular conditions. Their pipeline focuses on leveraging the anti-inflammatory, tissue repair, and immune-modulating properties of these cells for diseases with high unmet medical needs, such as acute graft versus host disease (aGVHD) and chronic heart failure.
Read more on MESO →Wix.com Ltd is a cloud-based development platform provider for millions of registered users worldwide. The company is engaged in web development and management that provides an easy-to-use powerful cloud-based platform of products through a freemium model. Its core products consist of three web editors: the Wix Editor, intended for users with basic technological skills, Wix ADI, intended for novice users and Corvid, intended for more tech-savvy users. The company's web development technology is built based on HTML5 and offers HTML5 compatible capabilities, web design and layout tools, domain hosting, and other marketing and workflow management applications and services. The geographic segments include North America, Europe, Latin America, Asia and others.
Read more on WIX →